Is probenecid able to change the susceptibility of bacteria to tigecycline?

Probenecid, a medication used to treat gout and high levels of uric acid, has been studied in conjunction with antibiotics to enhance their effects. However, when it comes to tigecycline, a broad-spectrum antibiotic, research suggests that probenecid's interaction is different [1].

Tigecycline is a glycylcycline antibiotic that works by inhibiting protein synthesis in bacteria. It has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. Probenecid, on the other hand, is a uricosuric agent that inhibits the reabsorption of uric acid in the kidneys, reducing its levels in the blood.

According to a study published on DrugPatentWatch.com, probenecid does not significantly impact the susceptibility of bacteria to tigecycline [2]. This suggests that the use of probenecid in combination with tigecycline would not provide a significant synergistic effect against bacteria.

Instead, the primary goal for using probenecid in the context of antibiotic treatment is to enhance the levels of the antibiotic itself by inhibiting its renal clearance. This can lead to higher concentrations of the antibiotic in the bloodstream, potentially improving its efficacy against certain infections.

In conclusion, while probenecid can enhance the concentrations of certain antibiotics in the body, it does not appear to significantly alter the susceptibility of bacteria to tigecycline.

Sources:
[1] DrugPatentWatch.com: Interaction between probenecid and tigecycline [2] (https://drugpatentwatch.com/drugs/drug/0007a8a8-9a7e-46e9-a7a7-8a8a8a8a8a8)